Katarina has as a former inspector conducted sponsor, vendor and site inspections all over the world for EMA, WHO, MPA including joint inspections with FDA. She has also worked with all clinical trial phases and  companies of all sizes. Both as a GCP specialist and advisor, and as an auditor, conducted due diligence evaluations and participated in acquisition.

Her career spans both global pharmaceutical leaders and regulatory agencies, giving her a unique perspective on the challenges and opportunities across the industry.  Katarina has shaped quality and compliance functions internationally, delivering strategic initiatives and operational support in areas such as GxP quality, audits and inspections, R&D, IT, Phase I units and M&A. Always with a risk-based mindset.

She is recognised for her rare blend of strategic vision and hands-on expertise in clinical quality and compliance which gives her a unique perspective on the challenges and opportunities across the industry.